ZonMw
Promising Medicines for ME/CFS — Call Drug Repurposing
Deadline for detailed grant application: 8 September 2026, 14:00 CEST. Pre-selection project idea deadline was 17 March 2026 (passed). Full timeline: advisory committee review mid-June 2026, referee comments 14 October 2026, response deadline 4 November 2026, decision February 2027.
Last verified:
Details
| Funder | ZonMw |
| Budget | €600k–€1M per project (total pool €3.5M) |
| Deadline | 8 September 2026 |
| Duration | Up to 4 years |
| Consortium | No |
| Application | 2-stage: project idea (pre-proposal, deadline passed 17 March 2026) → detailed grant application (8 September 2026) |
| Frequency | One-off |
| Eligible countries | NL |
Eligibility & scope
Funds clinical research (Proof of Concept or Clinical Validation studies) into drug repurposing of existing off-patent medicines for ME/CFS patients in the Netherlands. Applicants must be Dutch legal entities (public or private law). Non-research organisations must provide ≥50% co-financing. Proposals must be submitted in English via My ZonMw.
More from ZonMw
ZonMw ValNAM 2026
Deadline: 15 Jun 2026€200,000-€500,000Strengthening Organization of Healthcare on the ABCSSS Islands
Deadline: 7 Jul 2026Up to €60,000 per project (total call budget €360,000)Reducing Drug Harm – Pre-proposals Phase 1 (NWA)
Deadline: 7 Jul 2026Up to €1,067,737.75 per pre-proposal (Phase 1); €4,270,951 total for Phase 2 joint applicationNWO Talentprogramme Vici ZonMw 2026
Deadline: 8 Sept 2026Up to €1,500,000NWO Talent Programme Vici – ZonMw 2026
Deadline: 8 Sept 2026Up to €1,500,000
Browse Related
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free